Clinical trial
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During…
NCT00409331 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00409331 |
|---|---|
| Title | Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment |
| Official title | A Phase II Study To Assess The Efficacy of Amifostine for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment With Intensity- Modulated Radiation Therapy (IMRT) for Parotid Salivary Sparing |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | MedImmune LLC Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Amifostine, Intensity- Modulated Radiation Therapy |
| Enrollment | 3 |
| Start date | Dec 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Dec 8, 2006 |
| Last update posted | Aug 7, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: